Xerostomia in Primary Care

Jennifer Hofmann Ribowsky, MS, PA-C
Wednesday April 19, 2017
Xerostomia, also known as dry mouth, is a relatively common condition that can present acutely or chronically and has a variety of different causes. Xerostomia, or hypo salivation, is often caused by several temporary and chronic conditions that lead to salivary gland hypofunction. Temporary causes include, most commonly, the short-term use of certain medications, infections, and dehydration.

Chronic causes of xerostomia include rheumatologic diseases such as Sjogren syndrome (most commonly) as well as rheumatoid arthritis, systemic lupus erythematosus and scleroderma; and other medical conditions, such as sarcoidosis, amyloidosis, and lymphoma. Medicinal causes of xerostomia can include drugs with antimuscarinic and antihistaminergic properties, such as diphenhydramine and other antihistamines. Specific medications most likely to cause dry mouth are certain psychotropic agents, for example, antidepressants, antipsychotics, opioids, and certain antihypertensive agents such as diuretics and angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers. Adverse effects of radiation for head and neck cancers are also associated with salivary gland damage, which causes acute and chronic xerostomia. Physical examination should include a thorough oral and intraoral assessment with attention to the major and minor salivary glands, oral mucosa, tongue, teeth, and lips, as well lymph nodes, skin, joints, and other organs that may indicate systemic disease.

Case Study

Samantha is a 51-year-old, generally healthy female who presents to your family practice office with progressive worsening of dry mouth and dry eyes for the past 10 to 12 months. She describes the dry mouth as a tacky, dry feeling requiring frequent sips of water with and without food and more recently at night. She has noticed difficulty swallowing food without water. She has tried various sour lemon candies and even lemon juice in water to try and improve her salivation, but with little improvement. Samantha also reports dry, cracked tongue and lips with frequent chapping and cracking. She has had to visit the dentist for cavities 3 times over the past 2 years.

In addition to dry mouth and hypo salivation, Samantha reports progressive worsening of dry eyes over the past 12 to 18 months. She describes bilateral eye dryness, grittiness, and soreness with the need to use artificial eye drops very frequently. Samantha reports increased fatigue and occasional joint pains without swelling, which she attributes to aging. Her medical history is otherwise unremarkable, and she does not take medications on a regular basis. She denies fever, chills, rashes, and weight changes. She is a nonsmoker and drinks less than 1 to 2 glasses of red wine per month. She denies sick contacts or recent travel.

DISCUSSION QUESTION: What additional subjective and objective information would you want to know about Samantha’s illness? Is there diagnostic testing to consider?

ANSWER: Additional information to aid the diagnostic process of xerostomia includes review of recent and past infections such as HIV and hepatitis C, assessment of medications including OTC and complementary or alternative therapies, and consideration of history of head and neck irradiation. A review of systems should focus on skin, joint and muscle pains, cough or dyspnea, gastrointestinal symptoms, and lymph nodes, which may reveal rheumatologic causes for xerostomia.

Samantha’s physical examination reveals bilateral conjunctival injection, absence of salivary pooling sublingually with dry intraoral mucous membranes and a dry, fissured tongue with atrophic papillae. She also has cracking and dryness of the lips. There is mild tenderness bilaterally in the parotid glands without swelling. There is no localized or generalized lymphadenopathy.

Additional testing in the patient who presents with xerostomia is guided by the presence or absence of other symptoms, such as dry eyes and organ-specific symptoms. Diagnostic tests include assessment of saliva production, blood tests, and salivary gland biopsy. Assessment of salivary gland function may include whole sialometry, which directly measures unstimulated or stimulated saliva production as well as salivary gland imaging with ultrasound or MRI. Serologic studies should include antinuclear antibodies (ANA) by immunofluorescence staining assay, anti-Ro/SSA and anti-La/SSB antibodies, which are strongly indicative of Sjogren syndrome, and rheumatoid factor. Labial salivary gland biopsy is a useful tool to assess the cause of salivary gland dysfunction and assists in the diagnosis of Sjogren syndrome.

DISCUSSION QUESTION: What is your initial diagnosis for Samantha’s presentation?

ANSWER: Based on Samantha’s history and physical examination of chronic progressive dry eyes and dry mouth (sicca symptoms), fatigue a positive ANA, and positive anti-Ro/SSA and r anti-La/SSB antibodies, her diagnosis is primary Sjogren syndrome. Salivary gland biopsy is pending but will likely reveal focal lymphocytic sialadenitis.

DISCUSSION QUESTION: What are the management options for Sjogren syndrome and xerostomia?

ANSWER: General management for dry mouth, regardless of cause, includes preventing dry mouth with frequent oral hydration; avoidance of irritating oral agents such as coffee, acidic drinks, and tobacco; and adequate humidification. Patients should be encouraged to stimulate salivary flow with sugar-free sucking candies, lozenges, and chewing gums. Regular dental care with dentist visits at a minimum of every 6 months, daily flossing, fluoridated mouth rinses, and the use of dry mouth fluoridated toothpaste are also essential. More specific therapies for dry mouth include saliva substitutes in sprays, rinses, or gels form, which contain a combination of carboxymethylcellulose, polyethylene glycol, sorbitol with more viscosity than water.

Oral medications that stimulate saliva production may be used when topical therapies are inadequate. Pilocarpine and cevimeline are cholinergic agonists administered orally 3 to 4 times daily. Both pilocarpine and cevimeline are effective for dry mouth and dry eyes; however, adverse effects may limit long-term tolerability. Cholinergic adverse effects are dose dependent and include ushing, sweating, nausea, vomiting and diarrhea, and frequent urination.

Summary

Xerostomia is a symptom with several different etiologies ranging from medications to Sjogren syndrome. It is important to determine the cause of xerostomia. General measures for dry mouth management include oral hydration with water, sugar-free lozenges and gum, meticulous oral hygiene and dental care, and avoidance of irritating and acidic foods and beverages. Saliva substitutes may be used in addition to these other measures. When topical therapies are inadequora oral pilocarpine or cevimeline may improve dry mouth and related sicca symptoms.

Recommended Reading

Plemons JM, Al-Hashimi I, Marek CL; American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: Executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2014;145(8):867-873.
Kruszka P, O’Brian RJ. Diagnosis and management of Sjogren syndrome. Am Fam Physician. 2009;79(6):465-470.


Jennifer Hofmann Ribowsky, MS, PA-C, is a physician assistant with several years of clinical experience in primary care outpatient medicine and a master’s degree in clinical pharmacology. Her current academic position is clinical associate professor at the Pace University Lenox Hill Hospital PA Program and primary course instructor for medical pharmacology courses. 





Current Issue

The Educated Patient

Sara Marlow, MSN, RN, PHN, FNP-C
Sunburn is still a major health issue that can be prevented.
Kristen Marjama, DNP, FNP-BC
The National Health Interview Survey in 2014 estimated that 17.7 million adults and 6.3 million children had asthma.
Mary McCormack, MSN, APNC, MPH
The World Gastroenterology Organization describes the prevalence of celiac disease as a “statistical iceberg” in today’s health climate.
Melissa DeCapua, DNP, PMHNP-B-C
Diabetic retinopathy causes more losses of vision worldwide than any other eye disease, affecting 33% of the 285 million individuals suffering from diabetes.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
ONCLive
OTCGuide
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Advertise
Careers
Contact Us
Feedback
Privacy
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2017
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.